HER2-low Expressing Breast Cancer
4 clinical trials · Condition
◉ Watch HER2-low Expressing Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Phase II Neoadjuvant Pyrotinib Combined with Neoadjuvant Chemotherapy in HER2-low-expressing and HR Positive Early or Locally Advanced Breast Cancer: a Single-arm, Non-randomized, Single-center, Open Label Trial (NCT05165225) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2021-07-13 |
Track HER2-low Expressing Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.